Previous 10 | Next 10 |
Alkermes plc (ALKS) Q1 2019 Earnings Conference Call April 25, 2019 8:30 A.M. ET Company Participants Sandy Coombs - Vice President, Investor Relations Jim Frates - Chief Financial Officer Craig Hopkinson - Chief Medical Officer Richard Pops - Chief Executive Officer Confere...
The following slide deck was published by Alkermes plc in conjunction with their 2019 Q1 earnings Read more ...
Alkermes ( ALKS ) Q1 results : Revenues: $223.1M (-0.9%); Manufacturing and royalty revenues: $108.9M (-5.0%); Product sales: $99.5M (8.4%); R&D revenue: $14.7M (-21.4%). More news on: Alkermes plc, Healthcare stocks news, Earnings news and commentary, Read more ...
Alkermes (NASDAQ: ALKS ): Q1 Non-GAAP EPS of -$0.17 in-line; GAAP EPS of -$0.62. More news on: Alkermes plc, Earnings news and commentary, Healthcare stocks news, Read more ...
— First Quarter Revenues of $223.1 Million , Primarily Driven by ~8% Year-Over-Year Growth of Proprietary Product Net Sales — — Company Reports GAAP Net Loss per Share of $0.62 and Non-GAAP Net Loss per Share of $0....
DUBLIN , April 24, 2019 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that C. Todd Nichols , an executive with more than two decades of extensive commercial experience in the biopharmaceutical sector, will become the company's Senior Vice President of Sales and ...
Laurence Doud III, former CEO of Rochester Drug Co-Operative, was indicted yesterday by a Manhattan federal grand jury on charges of narcotics conspiracy and conspiracy to defraud the Drug Enforcement Administration (DEA) related to the distribution of "tens of millions" of opioid painkill...
DUBLIN , April 18, 2019 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:30 a.m. ET ( 1:30 p.m. BST ) on Thursday, Apr. 25, 2019 , to discuss the company's first quarter 2019 financial results. Management will also provide an ...
The U.S. Depart of Justice has charged 60 people , including 31 physicians, with illegally prescribing and distributing opioid painkillers. The DOJ claims that the group, which includes 53 medical professionals, are tied to ~350K prescriptions and 32M pills. More news on: Endo Internation...
Results from a Phase 3b clinical trial, ALPINE , evaluating Alkermes plc's (NASDAQ: ALKS ) ARISTADA (aripiprazole lauroxil) and Johnson & Johnson (NYSE: JNJ ) unit Janssen Pharmaceuticals' INVEGA SUSTENNA (paliperidone palmitate) in 200 patients experiencing acute exacerbations of sc...
News, Short Squeeze, Breakout and More Instantly...
Alkermes plc (ALKS) is expected to report $0.64 for Q2 2024 Acerinox ADR (ANIOY) is expected to report for Q2 2024 Allegion plc (ALLE) is expected to report $1.77 for Q2 2024 Deutsche Bank AG (DB) is expected to report $0.43 for Q2 2024 Pathward Financial Inc. (CASH) is expected t...
Alkermes plc Reports Second Quarter 2024 Financial Results PR Newswire — Second Quarter Revenues of $399.1 Million — — Net Sales of Proprietary Products Increased Approximately 16% Year-Over-Year — — GAAP Net Income from C...
2024-07-22 10:45:03 ET Enbridge Inc (ENB) ENB is trading UP for the last 5 days, and it at trading at $36.59 with volume of 731,965 and a one day change of $0.05 (0.14%). Enbridge Inc has a 52-week low of 31.03 and a 52-week high of $38.36. The business's 50-day moving average price...